Ubrogepant - AbbVie/Merck & Co
At a glance
- Drug Originator Merck & Co
- Drug Licenced by AbbVie
- Drug Class Amides; Antimigraines; Cyclopentanes; Fluorine compounds; Piperidines; Pyridines; Pyrrolidines; Small molecules; Spiro compounds
- Mechanism of Action Calcitonin gene-related peptide receptor antagonists
- USA Patent Applicants ABBVIE
- USA Patents 14
- NDAs 1
- International Patents 103
- Patent Applications 148
Table of Contents
Disclaimer